CoChat

MicroRNA signatures in vitreous humour and plasma of patients with exudative AMD

Open access
Ménard, Catherine, Rezende, Flavio A., Miloudi, Khalil, Wilson, Ariel, Tétreault, Nicolas, Hardy, Pierre, SanGiovanni, John Paul, De Guire, Vincent, Sapieha, Przemyslaw · 2016 · Oncotarget
Cited by 93

The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.

Abstract

// Catherine Ménard 1 , Flavio A. Rezende 2 , Khalil Miloudi 4 , Ariel Wilson 3 , Nicolas Tétreault 1 , Pierre Hardy 5 , John Paul SanGiovanni 6 , Vincent De Guire 7 and Przemyslaw Sapieha 1,2,4 1 Department of Biochemistry, Maisonneuve-Rosemont Hospital Research Centre, University of Montreal, Montreal, Quebec, Canada 2 Department of Ophthalmology, Maisonneuve-Rosemont Hospital Research Centre, University of Montreal, Montreal, Quebec, Canada 3 Department of Engineering Physics, École Polytechnique de Montréal, Laser Processing and Plasmonics Laboratory, Montreal, Quebec, Canada 4 Departement of Neuroscience, McGill University, Montreal, Quebec, Canada 5 Departments of Pediatrics and Pharmacology, University of Montreal, Montreal, Quebec, Canada 6 Laboratory of Membrane Biochemistry and Biophysics, Nutritional Neuroscience Section, NIAAA, NIH, Bethesda, MD, United States of America 7 Department of Clinical Biochemistry, Maisonneuve-Rosemont Hospital, Quebec, Canada Correspondence to: Przemyslaw Sapieha, email: // Vincent De Guire, email: // Keywords : age-related macular degeneration, AMD, microRNAs, miRNA, biomarkers, Gerotarget Received : January 14, 2016 Accepted : March 10, 2016 Published : March 22, 2016 Abstract Age-related macular degeneration (AMD) is a leading cause of blindness worldwide affecting individuals over the age of 50. The neovascular form (NV AMD) is characterized by choroidal neovascularization (CNV) and responsible for the majority of central vision impairment. Using non-biased microRNA arrays and individual TaqMan qPCRs, we profiled miRNAs in the vitreous humour and plasma of patients with NV AMD. We identified a disease-associated increase in miR-146a and a decrease in miR-106b and miR-152 in the vitreous humour which was reproducible in plasma. Moreover, miR-146a/miR-106b ratios discriminated patients with NV AMD with an area under the Receiver Operating Characteristic curve (ROC AUC) of 0,977 in vitreous humour and 0,915 in plasma suggesting potential for a blood-based diagnostic. Furthermore, using the AMD Gene Consortium (AGC) we mapped a NV AMD-associated SNP (rs1063320) in a binding site for miR-152-3p in the HLA-G gene. The relationship between our detected miRNAs and NV AMD related genes was also investigated using gene sets derived from the Ingenuity Pathway Analysis (IPA). To our knowledge, our study is the first to correlate vitreal and plasma miRNA signatures with NV AMD, highlighting potential future worth as biomarkers and providing insight on NV AMD pathogenesis.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.18632/oncotarget.8280

Cites

14 of 14 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 14 references

Cited by

See all 93

Metadata

Authors
Ménard, C., Rezende, F. A., Miloudi, K., Wilson, A., Tétreault, N., Hardy, P., SanGiovanni, J. P., De Guire, V., & Sapieha, P.
Venue
Oncotarget
Published
2016-03-22
Volume
7
Issue
15
Pages
19171-19184
ISSN
1949-2553 (ISSN-L)
OpenAlex
W2310003175
Cited by
93
References
14
FWCI
11.12
Type
journal article
Language
en
Open access
diamond

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: MicroRNA signatures in vitreous humour and plasma of patients with exudative AMD. https://app.cochat.ai/papers/10.18632/oncotarget.8280
The paper
Ménard, C., Rezende, F. A., Miloudi, K., Wilson, A., Tétreault, N., Hardy, P., SanGiovanni, J. P., De Guire, V., & Sapieha, P. (2016). MicroRNA signatures in vitreous humour and plasma of patients with exudative AMD. Oncotarget. https://doi.org/10.18632/oncotarget.8280

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.